Enlivex Therapeutics
Open
$0.82
Prev. Close
$0.83
High
$0.82
Low
$0.82
Market Snapshot
$19.47M
0.0
-0.73
36
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
emptyResult
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
Recently from Cashu
Enlivex Advances Allocetra, Promising New Therapy for Severe Sepsis and Immune Modulation
Enlivex Therapeutics Advances in Cell Therapy with Promising Clinical Results In a significant advancement for Enlivex Therapeutics, the company showcases promising outcomes from its leading investiga…
Enlivex Therapeutics Progresses Allocetra™ Cell Therapy in Immuno-Oncology Clinical Trials
Enlivex Therapeutics Advances Cell Therapy in Immuno-Oncology Enlivex Therapeutics, a company specializing in the field of immunology, focuses its efforts on developing innovative cell therapies that…
Enlivex Therapeutics: Breakthrough Clinical Results for Immunotherapy Product Allocetra in Critical Care
Enlivex Therapeutics Advances in Immunotherapy with Groundbreaking Clinical Trial Results Enlivex Therapeutics, a clinical-stage immunotherapy company, announces significant advancements in its clinic…
Enlivex Therapeutics Advances Allocetra™ Immunotherapy for Revolutionary Sepsis Treatment Solutions
### Enlivex Therapeutics Advances in Immunotherapy for Sepsis Treatment Enlivex Therapeutics is making significant strides in the field of immunotherapy, specifically targeting the treatment of sepsis…